CA Patent

CA2356829A1 — Method for treating asthma using pregabalin

Assigned to Warner Lambert Co LLC · Expires 2002-03-22 · 24y expired

What this patent protects

This invention relates to a method for preventing asthma and related inflammatory disease in mammals. This invention also relates to a method for treating or alleviating the symptoms of asthma and related inflammatory disease in mammals.

USPTO Abstract

This invention relates to a method for preventing asthma and related inflammatory disease in mammals. This invention also relates to a method for treating or alleviating the symptoms of asthma and related inflammatory disease in mammals.

Drugs covered by this patent

Patent Metadata

Patent number
CA2356829A1
Jurisdiction
CA
Classification
—
Expires
2002-03-22
Drug substance claim
No
Drug product claim
No
Assignee
Warner Lambert Co LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.